Artemisinin as a therapeutic vs. its more complex Artemisia source material
- 21 December 2022
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 40 (7), 1158-1169
- https://doi.org/10.1039/d2np00072e
Abstract
Covering: up to 2017–2022 Many small molecule drugs are first discovered in nature, commonly the result of long ethnopharmacological use by people, and then characterized and purified from their biological sources. Traditional medicines are often more sustainable, but issues related to source consistency and efficacy present challenges. Modern medicine has focused solely on purified molecules, but evidence is mounting to support some of the more traditional uses of medicinal biologics. When is a more traditional delivery of a therapeutic appropriate and warranted? What studies are required to establish validity of a traditional medicine approach? Artemisia annua and A. afra are two related but unique medicinal plant species with long histories of ethnopharmacological use. A. annua produces the sesquiterpene lactone antimalarial drug, artemisinin, while A. afra produces at most, trace amounts of the compound. Both species also have an increasing repertoire of modern scientific and pharmacological data that make them ideal candidates for a case study. Here accumulated recent data on A. annua and A. afra are reviewed as a basis for establishing a decision tree for querying their therapeutic use, as well as that of other medicinal plant species.Funding Information
- National Center for Complementary and Integrative Health (2R15AT008277-02)
This publication has 102 references indexed in Scilit:
- Evaluation of Antidiabetic Activity and Associated Toxicity ofArtemisia afraAqueous Extract in Wistar RatsEvidence-Based Complementary and Alternative Medicine, 2013
- Dried Whole Plant Artemisia annua as an Antimalarial TherapyPLOS ONE, 2012
- Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countriesMalaria Journal, 2011
- In vitro trematocidal effects of crude alcoholic extracts of Artemisia annua, A. absinthium, Asimina triloba, and Fumaria officinalisZeitschrift für Parasitenkunde, 2011
- Design, Synthesis, and Study of a Mycobactin−Artemisinin Conjugate That Has Selective and Potent Activity against Tuberculosis and MalariaJournal of the American Chemical Society, 2011
- Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseasesPhytochemistry Reviews, 2010
- Efficacy of Artemisia afra phytotherapy in experimental tuberculosisTuberculosis, 2009
- Artemisinins Inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense In Vitro GrowthAntimicrobial Agents and Chemotherapy, 2007
- Reflections on the ‘discovery’ of the antimalarial qinghaoBritish Journal of Clinical Pharmacology, 2006
- Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2004